Why Block Hunger at Brain …. If We Can Boost Satiety at Stomach ?
Prof. Dr. Mohamed Elhashemy
October 26, 2008
A Danish research, published in October 2008, led by Professor Arne Astrup from the University of Copenhagen, studied the effect of a new hunger suppressing drug named tesofensine which is a triple monoamine re-uptake inhibitor. They split a group of 203 obese patients into two groups.
First group were given a once-daily pill of tesofensine 0.5 mg and told to go on a moderate diet, and the other group were given "dummy" placebo pills.
After six months, the researchers found that while mean weight loss for those on placebo was under 5 pounds, those on a 0.5 mg dose once daily for 6 months of tesofensine lost almost 25 pounds, which is twice that achieved by the most effective weight-loss drugs.
But tesofensine did produce many side-effects including: raising patients' blood pressure, raising heart rate, and insomnia.
Since the drug works by suppressing hunger at brain level which may reveal in the future more serious side effects as those discovered recently with rimonabant, I think that we have a better alternative which can produce greater loss of weight in a natural way by dealing with the stomach satiety instead of blocking brain hunger. This consists of a combo of Luqaimat diet and the boosting Elhashemy's Stomach Satiety Spot "ESSS". This combo could lead to complete stomach satiety, hence outstanding weight loss.
Simulation training, and to a lesser extent 3D animation training on virtual "ESSS" offers psychological; visual, and physiological effects that may induce obese people to feel satiated most of the day, hence losing a great percentage of their extra weight.
I am waiting for a reputable simulator manufacturer company to discuss with me how to develop such Stomach Satiety Simulator.
Currently, I am proceeding with a research to study the effect of watching 3D animation of the impact of eating nuts on ESSS. The research will include 20 of my obese patients (BMI 40 or more), whom I will also advise to eat 3 successive doses of Luqaimat made of nuts.
The results of a group of another 40 obese patients of nearly similar BMI who will not see the 3D animation, nor eat the three successive doses of nuts each day, will be used as a control group. All 60 patients will be under Luqaimat diet for 2 months.
Expected Results:
With my innovated traditional Luqaimat diet method, obese patients of BMI 40 or more usually lose average of 20 pounds in 2 months, and 45 pounds within 6 months. Most dietitians may consider this great achievement since it goes through natural dieting with no drug intake, nor restriction of any food item, they are only trained to restrict their food volume intake to the size of Luqaimat. Groundbreaking achievement is expected to occur when I train the group of 20 obese patients using stomach satiety spot animation settings together with traditional Luqaimat diet.
The above mentioned planed study is based on my past experience with 3 of my obese patients, who lost average of 30 pounds in 2 months by using the above mentioned combo. I consider such results outstanding in the field of weight loss. I expect that the new combo of Luqaimat and the boosting of Elhashemy's ESSS could result in more than 70 pounds loss in 6 months for those patients with BMI 40 or more. These results are very close to those of bariatric surgery.
First group were given a once-daily pill of tesofensine 0.5 mg and told to go on a moderate diet, and the other group were given "dummy" placebo pills.
After six months, the researchers found that while mean weight loss for those on placebo was under 5 pounds, those on a 0.5 mg dose once daily for 6 months of tesofensine lost almost 25 pounds, which is twice that achieved by the most effective weight-loss drugs.
But tesofensine did produce many side-effects including: raising patients' blood pressure, raising heart rate, and insomnia.
Since the drug works by suppressing hunger at brain level which may reveal in the future more serious side effects as those discovered recently with rimonabant, I think that we have a better alternative which can produce greater loss of weight in a natural way by dealing with the stomach satiety instead of blocking brain hunger. This consists of a combo of Luqaimat diet and the boosting Elhashemy's Stomach Satiety Spot "ESSS". This combo could lead to complete stomach satiety, hence outstanding weight loss.
Simulation training, and to a lesser extent 3D animation training on virtual "ESSS" offers psychological; visual, and physiological effects that may induce obese people to feel satiated most of the day, hence losing a great percentage of their extra weight.
I am waiting for a reputable simulator manufacturer company to discuss with me how to develop such Stomach Satiety Simulator.
Currently, I am proceeding with a research to study the effect of watching 3D animation of the impact of eating nuts on ESSS. The research will include 20 of my obese patients (BMI 40 or more), whom I will also advise to eat 3 successive doses of Luqaimat made of nuts.
The results of a group of another 40 obese patients of nearly similar BMI who will not see the 3D animation, nor eat the three successive doses of nuts each day, will be used as a control group. All 60 patients will be under Luqaimat diet for 2 months.
Expected Results:
With my innovated traditional Luqaimat diet method, obese patients of BMI 40 or more usually lose average of 20 pounds in 2 months, and 45 pounds within 6 months. Most dietitians may consider this great achievement since it goes through natural dieting with no drug intake, nor restriction of any food item, they are only trained to restrict their food volume intake to the size of Luqaimat. Groundbreaking achievement is expected to occur when I train the group of 20 obese patients using stomach satiety spot animation settings together with traditional Luqaimat diet.
The above mentioned planed study is based on my past experience with 3 of my obese patients, who lost average of 30 pounds in 2 months by using the above mentioned combo. I consider such results outstanding in the field of weight loss. I expect that the new combo of Luqaimat and the boosting of Elhashemy's ESSS could result in more than 70 pounds loss in 6 months for those patients with BMI 40 or more. These results are very close to those of bariatric surgery.
Print
Email
